chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination complication, Vaccination site warmth
Clinical narrative: diarrhea; severe chills, could not get warm; hurt to walk; body aches; fever; headaches; hot burning sensation at the site of injection; was in bed all day; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot burning sensation at the site of injection), DIARRHOEA (diarrhea), CHILLS (severe chills, could not get warm), GAIT DISTURBANCE (hurt to walk) and PYREXIA (fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in October 2020.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE WARMTH (hot burning sensation at the site of injection), CHILLS (severe chills, could not get warm), GAIT DISTURBANCE (hurt to walk), PYREXIA (fever) and HEADACHE (headaches). On 21-Jan-2021, the patient experienced DIARRHOEA (diarrhea). On 20-Jan-2021, VACCINATION SITE WARMTH (hot burning sensation at the site of injection) had resolved. On 21-Jan-2021, DIARRHOEA (diarrhea), GAIT DISTURBANCE (hurt to walk) and PYREXIA (fever) had resolved, CHILLS (severe chills, could not get warm) outcome was unknown. At the time of the report, HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient used Tylenol as treatment.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No specific follow-up information recorded.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement
Clinical narrative: Blood pressure of 185/125; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Blood pressure of 185/125) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (Blood pressure of 185/125). At the time of the report, BLOOD PRESSURE INCREASED (Blood pressure of 185/125) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 185/125 185/125 no unit availble.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included nurse at the facility gave the patient Benadryl 15 milligram to help.   Reporter did not allow further contact
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Vaccination site swelling
Clinical narrative: Arm is sore; Headache; Swollen at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is sore), HEADACHE (Headache) and VACCINATION SITE SWELLING (Swollen at the injection site) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included GABAPENTIN, ATENOLOL, CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]), METFORMIN HYDROCHLORIDE, SITAGLIPTIN PHOSPHATE MONOHYDRATE (JANUMET) and GLIMEPIRIDE for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm is sore), HEADACHE (Headache) and VACCINATION SITE SWELLING (Swollen at the injection site). At the time of the report, PAIN IN EXTREMITY (Arm is sore), HEADACHE (Headache) and VACCINATION SITE SWELLING (Swollen at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2021: No specific follow-up information recorded.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site mass, Injection site pain, Peripheral swelling
Clinical narrative: Left arm swollen; Bump at the injection site; It is tender; felt Tired; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Left arm swollen), INJECTION SITE MASS (Bump at the injection site), INJECTION SITE PAIN (It is tender) and FATIGUE (felt Tired) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CHLORPHENAMINE MALEATE, IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE (ADVIL ALLERGY SINUS) and MULTI VITAMINS & MINERALS for an unknown indication.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PERIPHERAL SWELLING (Left arm swollen), INJECTION SITE MASS (Bump at the injection site), INJECTION SITE PAIN (It is tender) and FATIGUE (felt Tired). At the time of the report, PERIPHERAL SWELLING (Left arm swollen), INJECTION SITE MASS (Bump at the injection site), INJECTION SITE PAIN (It is tender) and FATIGUE (felt Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product reported was blood pressure medication, cholesterol medication. No treatment information provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: discoloration all over her body / shape is strawberry and color is white; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (discoloration all over her body / shape is strawberry and color is white) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Infection since 12-Jan-2021. Concomitant products included LEVOFLOXACIN (LEVAQUIN) from 12-Jan-2021 to an unknown date for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced SKIN DISCOLOURATION (discoloration all over her body / shape is strawberry and color is white). At the time of the report, SKIN DISCOLOURATION (discoloration all over her body / shape is strawberry and color is white) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment information provided.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itching at the injection site; the injection site is also inflamed; I tested positive for covid-19; This spontaneous case was reported by a nurse and describes the occurrence of COVID-19 (I tested positive for covid-19) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced COVID-19 (I tested positive for covid-19). At the time of the report, COVID-19 (I tested positive for covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Nasal congestion, Rhinorrhoea
Clinical narrative: covid-19; runny nose; congestion; loss of taste; loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (covid-19) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced COVID-19 (covid-19). At the time of the report, COVID-19 (covid-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Urticaria
Clinical narrative: red circular welt welt which was about the size of a silver dollar; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness) and URTICARIA (red circular welt welt which was about the size of a silver dollar) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN (soreness). On 14-Feb-2021, the patient experienced URTICARIA (red circular welt welt which was about the size of a silver dollar). At the time of the report, PAIN (soreness) and URTICARIA (red circular welt welt which was about the size of a silver dollar) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment Benadryl
Sex: M
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain, Pyrexia, Vomiting
Clinical narrative: Fever 99 F; Nausea; Chills again; Aches & Pain all over his body; vomiting; Fever 100 F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches & Pain all over his body), VOMITING (vomiting), PYREXIA (Fever 100 F), CHILLS (Chills) and NAUSEA (Nausea) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No adverse event reported).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced PAIN (Aches & Pain all over his body), VOMITING (vomiting), PYREXIA (Fever 100 F) and CHILLS (Chills). On 21-Jan-2021, the patient experienced NAUSEA (Nausea) and CHILLS (Chills again). On an unknown date, the patient experienced PYREXIA (Fever 99 F). On 17-Jan-2021, PAIN (Aches & Pain all over his body), VOMITING (vomiting), PYREXIA (Fever 100 F) and CHILLS (Chills) had resolved. At the time of the report, NAUSEA (Nausea) and CHILLS (Chills again) had resolved and PYREXIA (Fever 99 F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment Advil
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Bone pain, Dyspepsia, Fatigue, Injection site pain
Clinical narrative: indigestion; SENSITIVE TUMMY AREA; Couldn't sleep well because all my body hurt; bone started hurting a lot from my neck down to my feet; really tired all weekend; didn't do anything; the day of the vaccine, arm started to hurt; muscle started hurting a lot from my neck down to my feet; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (SENSITIVE TUMMY AREA), SLEEP DEFICIT (Couldn't sleep well because all my body hurt), DYSPEPSIA (indigestion), BONE PAIN (bone started hurting a lot from my neck down to my feet) and FATIGUE (really tired all weekend; didn't do anything) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Allergy. Concomitant products included PANTOPRAZOLE (Protonix), MULTIVITAMIN (Centrum silver vitamin), CALCIUM CARBONATE, COLECALCIFEROL (CALTRATE 600 + D), ACETYLSALICYLIC ACID (ASPIRIN) and ASCORBIC ACID (VITAMIN C).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced SLEEP DEFICIT (Couldn't sleep well because all my body hurt), BONE PAIN (bone started hurting a lot from my neck down to my feet), FATIGUE (really tired all weekend; didn't do anything), INJECTION SITE PAIN (the day of the vaccine, arm started to hurt) and MYALGIA (muscle started hurting a lot from my neck down to my feet). On 18-Jan-2021, the patient experienced ABDOMINAL DISCOMFORT (SENSITIVE TUMMY AREA) and DYSPEPSIA (indigestion). On 18-Jan-2021, BONE PAIN (bone started hurting a lot from my neck down to my feet) and MYALGIA (muscle started hurting a lot from my neck down to my feet) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (SENSITIVE TUMMY AREA), SLEEP DEFICIT (Couldn't sleep well because all my body hurt), DYSPEPSIA (indigestion) and FATIGUE (really tired all weekend; didn't do anything) outcome was unknown and INJECTION SITE PAIN (the day of the vaccine, arm started to hurt) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Sleep deficit
Clinical narrative: indigestion; SENSITIVE TUMMY AREA; Couldn't sleep well because all my body hurt; bone started hurting a lot from my neck down to my feet; really tired all weekend; didn't do anything; the day of the vaccine, arm started to hurt; muscle started hurting a lot from my neck down to my feet; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (SENSITIVE TUMMY AREA), SLEEP DEFICIT (Couldn't sleep well because all my body hurt), DYSPEPSIA (indigestion), BONE PAIN (bone started hurting a lot from my neck down to my feet) and FATIGUE (really tired all weekend; didn't do anything) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Allergy. Concomitant products included PANTOPRAZOLE (Protonix), MULTIVITAMIN (Centrum silver vitamin), CALCIUM CARBONATE, COLECALCIFEROL (CALTRATE 600 + D), ACETYLSALICYLIC ACID (ASPIRIN) and ASCORBIC ACID (VITAMIN C).    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced SLEEP DEFICIT (Couldn't sleep well because all my body hurt), BONE PAIN (bone started hurting a lot from my neck down to my feet), FATIGUE (really tired all weekend; didn't do anything), INJECTION SITE PAIN (the day of the vaccine, arm started to hurt) and MYALGIA (muscle started hurting a lot from my neck down to my feet). On 18-Jan-2021, the patient experienced ABDOMINAL DISCOMFORT (SENSITIVE TUMMY AREA) and DYSPEPSIA (indigestion). On 18-Jan-2021, BONE PAIN (bone started hurting a lot from my neck down to my feet) and MYALGIA (muscle started hurting a lot from my neck down to my feet) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (SENSITIVE TUMMY AREA), SLEEP DEFICIT (Couldn't sleep well because all my body hurt), DYSPEPSIA (indigestion) and FATIGUE (really tired all weekend; didn't do anything) outcome was unknown and INJECTION SITE PAIN (the day of the vaccine, arm started to hurt) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Pyrexia, Tremor
Clinical narrative: Shaky; Very weak; Tired; low grade fever (99 F); This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaky), ASTHENIA (Very weak), FATIGUE (Tired) and PYREXIA (low grade fever (99 F)) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced TREMOR (Shaky), ASTHENIA (Very weak), FATIGUE (Tired) and PYREXIA (low grade fever (99 F)). At the time of the report, TREMOR (Shaky), ASTHENIA (Very weak), FATIGUE (Tired) and PYREXIA (low grade fever (99 F)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site erythema, Limb discomfort, Peripheral swelling, Vaccination site warmth
Clinical narrative: arm was sensitive; red arm; arm a little bit swollen; injection site is redder (4 inches long); arm warm to the touch; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (arm was sensitive), ERYTHEMA (red arm), PERIPHERAL SWELLING (arm a little bit swollen), VACCINATION SITE WARMTH (arm warm to the touch) and INJECTION SITE ERYTHEMA (injection site is redder (4 inches long)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol (Medicine taking for cholesterol) and Stye (Taking eyedrops). Concomitant products included NEOMYCIN and POLYMYXIN for Stye.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced LIMB DISCOMFORT (arm was sensitive), ERYTHEMA (red arm), PERIPHERAL SWELLING (arm a little bit swollen) and INJECTION SITE ERYTHEMA (injection site is redder (4 inches long)). On an unknown date, the patient experienced VACCINATION SITE WARMTH (arm warm to the touch). At the time of the report, LIMB DISCOMFORT (arm was sensitive), ERYTHEMA (red arm), PERIPHERAL SWELLING (arm a little bit swollen), VACCINATION SITE WARMTH (arm warm to the touch) and INJECTION SITE ERYTHEMA (injection site is redder (4 inches long)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication, cholesterol and is taking some eyedrops for a stye (inflammation of the eyelid). Treatment medication included ice on the arm.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: Redness; Hives; Itching; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of   in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history reported.). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), VERAPAMIL and MEMANTINE HYDROCHLORIDE (NAMENDA).    On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Breast inflammation, Bursitis, Chills, Joint swelling, Pyrexia
Clinical narrative: a lot of inflammation on the left side: into my breast, into my knee, hip; inflammation on the left side: into my breast, into my knee, hip; inflammation on the left side: into my breast, into my knee, hip; teeth chattered for 4 hours; high fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of JOINT SWELLING (inflammation on the left side: into my breast, into my knee, hip) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02SL20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced JOINT SWELLING (inflammation on the left side: into my breast, into my knee, hip). At the time of the report, JOINT SWELLING (inflammation on the left side: into my breast, into my knee, hip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Headache, Myalgia
Clinical narrative: headache; muscle ache; fatigue; This spontaneous case was reported by a physician and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 18-Jan-2021.    On 09-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, COVID-19 (positive-negative): positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Urticaria
Clinical narrative: extreme facial swelling; extreme facial hives; This spontaneous case was reported by a nurse and describes the occurrence of SWELLING FACE (extreme facial swelling) and URTICARIA (extreme facial hives) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.). Concurrent medical conditions included Ulcer and Hypothyroidism. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, AMOXICILLIN for Tooth abscess, OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]).    On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced SWELLING FACE (extreme facial swelling) and URTICARIA (extreme facial hives). At the time of the report, SWELLING FACE (extreme facial swelling) and URTICARIA (extreme facial hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication included Benadryl
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: breakout with itchy rash all over body; breakout with itchy rash all over body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (breakout with itchy rash all over body) and PRURITUS (breakout with itchy rash all over body) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.    Co-suspect product included non-company product zytec for an unknown indication.    Concomitant products included SALBUTAMOL (ALBUTEROL HFA), ALPRAZOLAM (XANAX), APIXABAN (ELIQUIS), ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), ATORVASTATIN (LIPTOR [ATORVASTATIN]), BUMETANIDE (BUMEX), MINERALS NOS, VITAMINS NOS (CENTRUM A TO ZINC), COLECALCIFEROL (VIT D3), GABAPENTIN, LANSOPRAZOLE, LACTOBACILLUS ACIDOPHILUS (LACTOBACILLUS) and PRIMIDONE.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started zytec (unknown route) at an unspecified dose. On 17-Jan-2021, the patient experienced RASH (breakout with itchy rash all over body) and PRURITUS (breakout with itchy rash all over body). At the time of the report, RASH (breakout with itchy rash all over body) and PRURITUS (breakout with itchy rash all over body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Steroid shot and Zyrtec
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Eight to nine days after the shot the arm got sore and it is sore still; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Eight to nine days after the shot the arm got sore and it is sore still) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (Eight to nine days after the shot the arm got sore and it is sore still). At the time of the report, VACCINATION SITE PAIN (Eight to nine days after the shot the arm got sore and it is sore still) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: rash at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE RASH (rash at the injection site). At the time of the report, VACCINATION SITE RASH (rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site rash
Clinical narrative: Rash spreading to chest and arms; Rash in injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash spreading to chest and arms) and VACCINATION SITE RASH (Rash in injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced RASH (Rash spreading to chest and arms) and VACCINATION SITE RASH (Rash in injection site). At the time of the report, RASH (Rash spreading to chest and arms) and VACCINATION SITE RASH (Rash in injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment Antibiotics and cefadroxil
Sex: F
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: I just feel yucky; This spontaneous case was reported by an other and describes the occurrence of TASTE DISORDER (I just feel yucky) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no adverse event reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TASTE DISORDER (I just feel yucky). At the time of the report, TASTE DISORDER (I just feel yucky) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site warmth, Pain
Clinical narrative: pain in neck and ears; pain on left side of face, back, buttocks, legs,; Injection site hot; injection site became red; Injection site hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain in neck and ears), PAIN (pain on left side of face, back, buttocks, legs, ), INJECTION SITE WARMTH (Injection site hot), INJECTION SITE ERYTHEMA (injection site became red) and INJECTION SITE PAIN (Injection site hurting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced INJECTION SITE WARMTH (Injection site hot), INJECTION SITE ERYTHEMA (injection site became red) and INJECTION SITE PAIN (Injection site hurting). On 19-Jan-2021, the patient experienced PAIN (pain on left side of face, back, buttocks, legs, ). On 20-Jan-2021, the patient experienced PAIN (pain in neck and ears). At the time of the report, PAIN (pain in neck and ears) and PAIN (pain on left side of face, back, buttocks, legs, ) outcome was unknown and INJECTION SITE WARMTH (Injection site hot), INJECTION SITE ERYTHEMA (injection site became red) and INJECTION SITE PAIN (Injection site hurting) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site rash
Clinical narrative: rash on the arm; muscle aches, especially on legs; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash on the arm) and MYALGIA (muscle aches, especially on legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (rash on the arm) and MYALGIA (muscle aches, especially on legs). At the time of the report, VACCINATION SITE RASH (rash on the arm) and MYALGIA (muscle aches, especially on legs) outcome was unknown. Not Provided          No concomitant medications were provided.  No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced RASH (rash). At the time of the report, RASH (rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: red itchy rash at the injection site; red itchy rash at the injection site; red itchy rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red itchy rash at the injection site), VACCINATION SITE ERYTHEMA (red itchy rash at the injection site) and VACCINATION SITE RASH (red itchy rash at injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (red itchy rash at the injection site), VACCINATION SITE ERYTHEMA (red itchy rash at the injection site) and VACCINATION SITE RASH (red itchy rash at injection site). At the time of the report, VACCINATION SITE PRURITUS (red itchy rash at the injection site), VACCINATION SITE ERYTHEMA (red itchy rash at the injection site) and VACCINATION SITE RASH (red itchy rash at injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Received the vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPOSURE DURING PREGNANCY (Received the vaccine while pregnant) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOFLOXACIN (LOVENOX [LEVOFLOXACIN]) for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 08-May-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Received the vaccine while pregnant). At the time of the report, EXPOSURE DURING PREGNANCY (Received the vaccine while pregnant) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided .
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Pruritus, Rash erythematous
Clinical narrative: where the red rash is, it feels warm to the touch, like a pink rash; feels warm to the touch; The upper arm pretty much is red and it itches; feels tired; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (where the red rash is, it feels warm to the touch, like a pink rash), FEELING HOT (feels warm to the touch), PRURITUS (The upper arm pretty much is red and it itches) and FATIGUE (feels tired) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (where the red rash is, it feels warm to the touch, like a pink rash), FEELING HOT (feels warm to the touch), PRURITUS (The upper arm pretty much is red and it itches) and FATIGUE (feels tired). At the time of the report, RASH ERYTHEMATOUS (where the red rash is, it feels warm to the touch, like a pink rash), FEELING HOT (feels warm to the touch), PRURITUS (The upper arm pretty much is red and it itches) and FATIGUE (feels tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Vaccination site inflammation, Vaccination site pain, Vaccination site pruritus
Clinical narrative: injection site rash; it turned pretty pink and looks inflamed; 2 inches by 3 inches, itching and rash; it did hurt for a few days; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (it turned pretty pink and looks inflamed), VACCINATION SITE PRURITUS (2 inches by 3 inches, itching and rash), VACCINATION SITE PAIN (it did hurt for a few days) and INJECTION SITE RASH (injection site rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported).    On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced VACCINATION SITE PAIN (it did hurt for a few days). On 20-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (2 inches by 3 inches, itching and rash). On 21-Jan-2021, the patient experienced VACCINATION SITE INFLAMMATION (it turned pretty pink and looks inflamed). On an unknown date, the patient experienced INJECTION SITE RASH (injection site rash). On 15-Jan-2021, VACCINATION SITE PAIN (it did hurt for a few days) outcome was unknown. At the time of the report, VACCINATION SITE INFLAMMATION (it turned pretty pink and looks inflamed), VACCINATION SITE PRURITUS (2 inches by 3 inches, itching and rash) and INJECTION SITE RASH (injection site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and CHILLS (chills). At the time of the report, PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Bad Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Bad Headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Bad Headache). At the time of the report, HEADACHE (Bad Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site erythema, Injection site mass, Injection site pruritus
Clinical narrative: red large itchy node (like a lump); large itchy node; headache; fatigue; threw up four times; red large itchy node; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of INJECTION SITE MASS (red large itchy node (like a lump)), INJECTION SITE PRURITUS (large itchy node), HEADACHE (headache), FATIGUE (fatigue) and VOMITING (threw up four times) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE MASS (red large itchy node (like a lump)), INJECTION SITE PRURITUS (large itchy node), HEADACHE (headache), FATIGUE (fatigue), VOMITING (threw up four times) and INJECTION SITE ERYTHEMA (red large itchy node). At the time of the report, INJECTION SITE MASS (red large itchy node (like a lump)), INJECTION SITE PRURITUS (large itchy node), HEADACHE (headache), FATIGUE (fatigue), VOMITING (threw up four times) and INJECTION SITE ERYTHEMA (red large itchy node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: red large itchy node (like a lump); large itchy node; headache; fatigue; threw up four times; red large itchy node; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of INJECTION SITE MASS (red large itchy node (like a lump)), INJECTION SITE PRURITUS (large itchy node), HEADACHE (headache), FATIGUE (fatigue) and VOMITING (threw up four times) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history).    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE MASS (red large itchy node (like a lump)), INJECTION SITE PRURITUS (large itchy node), HEADACHE (headache), FATIGUE (fatigue), VOMITING (threw up four times) and INJECTION SITE ERYTHEMA (red large itchy node). At the time of the report, INJECTION SITE MASS (red large itchy node (like a lump)), INJECTION SITE PRURITUS (large itchy node), HEADACHE (headache), FATIGUE (fatigue), VOMITING (threw up four times) and INJECTION SITE ERYTHEMA (red large itchy node) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Hyperhidrosis, Pyrexia
Clinical narrative: Lightheaded; Sweating; Chills; Fever 103.7 F; This spontaneous case was reported by an other caregiver and describes the occurrence of DIZZINESS (Lightheaded), HYPERHIDROSIS (Sweating), CHILLS (Chills) and PYREXIA (Fever 103.7 F) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DIZZINESS (Lightheaded), HYPERHIDROSIS (Sweating), CHILLS (Chills) and PYREXIA (Fever 103.7 F). At the time of the report, DIZZINESS (Lightheaded), HYPERHIDROSIS (Sweating), CHILLS (Chills) and PYREXIA (Fever 103.7 F) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 26-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 04-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 04-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided No treatment information provided